Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial experience with a new prosthetic angioaccess device.

R N Garrison, R L Wathen, K E Richardson

    Southern Medical Journal
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recovery of <i>Campylobacter</i> from feed using different enrichment media.

    Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes·2021
    Same author

    Isolation of Salmonella spp. from Animal Feed.

    Methods in molecular biology (Clifton, N.J.)·2020
    Same author

    Optimizing buffering chemistry to maintain near neutral pH of broiler feed during pre-enrichment for Salmonella.

    Poultry science·2015
    Same author

    Salmonella in commercially manufactured feeds.

    Poultry science·2004
    Same author

    Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin.

    Circulation·2001
    Same author

    Progressive decrease in constrictor reactivity of the non-absorbing intestine during chronic sepsis.

    Shock (Augusta, Ga.)·2001
    Same journal

    The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

    Southern medical journal·2026
    Same journal

    α-Gal Syndrome in the South: Why We Need Treatment Trials, Not Just Tick Prevention.

    Southern medical journal·2026
    Same journal

    Association between Main Pancreatic Duct Size, Comorbidities, and Fistula Formation after Whipple Procedure for Pancreatic Cancer.

    Southern medical journal·2026
    Same journal

    Impact of Temperature Variation on Patients with Acute Severe Asthma.

    Southern medical journal·2026
    Same journal

    Assessing the Accuracy and Reliability of ChatGPT-4 to Answer Clinical EHR Messages in Sports Medicine.

    Southern medical journal·2026
    Same journal

    Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

    Southern medical journal·2026
    See all related articles

    The Hemasite angioaccess system shows promise for end-stage renal disease patients needing long-term vascular access. While facing challenges like infection and thrombosis, patient acceptance is high, especially with upper arm placement.

    Area of Science:

    • Nephrology
    • Vascular Surgery
    • Medical Devices

    Background:

    • Long-term vascular access is crucial for patients with end-stage renal disease (ESRD).
    • Vascular access complications like thrombosis and infection lead to significant morbidity and hospitalizations in ESRD patients.
    • The Hemasite angioaccess system was developed to address these access issues.

    Purpose of the Study:

    • To review the initial clinical experience with the Hemasite angioaccess system.
    • To evaluate the safety, efficacy, and patency rates of the Hemasite system in ESRD patients.

    Main Methods:

    • A retrospective review of 90 Hemasite devices implanted in 77 patients over 24 months.
    • Analysis of implantation indications (emergency, initial, convenience), complications, and patency rates.

    Related Experiment Videos

  • Comparison of outcomes between graftless and grafted Hemasite models, and placement locations.

    • Main Results:

    • The Hemasite system was used for emergency access (39%), initial access (38%), and convenience (23%).
    • Device failure was attributed to 28 infections and 18 thromboses; no device-related deaths occurred.
    • One-year patency was 46% overall, with 50% for the grafted model in the upper arm, which showed the highest success rate.

    Conclusions:

    • The Hemasite angioaccess system demonstrates high patient acceptance and potential for ESRD vascular access.
    • While patency rates are currently lower than some alternatives, upper arm placement of the grafted model shows promising results.
    • Further research is needed to optimize Hemasite system performance and compare it directly with established vascular access methods.